2023/02/08 21:10:55 | |
---|---|
Price | |
341.575 USD | |
Difference | 0.56% (1.90) |
ISIN | US5324571083 |
Symbol | LLY |
Exchange | NYSE |
Currency | USD |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 312,523 EUR |
Benchmark | S&P 500 |
Bid (Bid size) | 341.51 USD (100) |
Ask (Ask size) | 341.61 USD (200) |
Open | 338.56 USD |
High | 342.87 USD |
Low | 337.82 USD |
Close (prev. day) | 339.68 USD |
VWAP | 340.55669 USD |
Volume (pcs) | 1,443,868 |
Trading volume | 491,776,899.75 |
Number of trades | 39,285 |
Last size | 100 |
Related Futures | 15 |
Related Options | - |
Date | Headline | Download | |
2023/02/07 |
![]() |
Global Equity Ratings |
![]() |
2023/01/30 |
![]() |
Global Equity Ratings |
![]() |
2023/01/09 |
![]() |
Global Equity Ratings |
![]() |
2022/12/19 |
![]() |
Global Equity Ratings |
![]() |
2022/11/28 |
![]() |
Global Equity Ratings |
![]() |
2023/02/08 21:10:55 | |
---|---|
Price | |
341.575 USD | |
Difference | 0.56% (1.90) |
ISIN | US5324571083 |
Symbol | LLY |
Exchange | NYSE |
Currency | USD |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 312,523 EUR |
Benchmark | S&P 500 |
Bid (Bid size) | 341.51 USD (100) |
Ask (Ask size) | 341.61 USD (200) |
Open | 338.56 USD |
High | 342.87 USD |
Low | 337.82 USD |
Close (prev. day) | 339.68 USD |
VWAP | 340.55669 USD |
Volume (pcs) | 1,443,868 |
Trading volume | 491,776,899.75 |
Number of trades | 39,285 |
Last size | 100 |
6m | 1Y | 3Y | |
Perf (%) | +12.73% | +39.47% | +132.01% |
Perf (abs.) | +38.36 | +96.13 | +193.27 |
Beta | 0.42 | 0.49 | 0.64 |
Volatility | 26.68 | 27.29 | 34.37 |
Ø price 5 days | Ø volume 5 days (pcs.) | 337.938 USD (5,443,617) |
Ø price 30 days | Ø volume 30 days (pcs.) | 352.474 USD (2,793,506) |
Ø price 100 days | Ø volume 100 days (pcs.) | 348.308 USD (3,047,626) |
Ø price 250 days | Ø volume 250 days (pcs.) | 317.766 USD (2,904,788) |
YTD High | date | 384.440 USD (2023/01/24) |
YTD Low | date | 302.140 USD (2023/01/24) |
52 Weeks High | date | 384.440 USD (2023/01/24) |
52 Weeks Low | date | 231.870 USD (2022/02/14) |
Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
Xetra | 2023/02/08 | 17:35 | 317.25 EUR | 0.12 | 21 |
Vienna Stock Exchange | 2023/02/08 | 17:32 | 316.75 EUR | 0.00 | 2 |
Tradegate | 2023/02/08 | 19:22 | 319.55 EUR | 0.29 | 54 |
Stuttgart | 2023/02/08 | 15:40 | 317.70 EUR | 0.16 | 5 |
SIX Swiss Exchange | 2023/02/08 | 17:30 | 274.00 CHF | 0.00 | 1 |
NYSE | 2023/02/08 | 21:10 | 341.575 USD | 491.81 | 39,287 |
Munich | 2023/02/08 | 08:00 | 315.75 EUR | 0.00 | 1 |
London Stock Exchange | 2021/12/10 | 15:37 | 225.3104 CHF | 0.02 | 1 |
Hanover | 2023/02/08 | 08:17 | 315.65 EUR | 0.00 | 1 |
Hamburg | 2023/02/08 | 08:17 | 315.65 EUR | 0.00 | 1 |
Frankfurt | 2023/02/08 | 16:32 | 316.95 EUR | 0.02 | 4 |
Duesseldorf | 2023/02/08 | 21:00 | 317.65 EUR | 0.00 | 11 |
Berlin | 2023/02/08 | 08:08 | 315.60 EUR | 0.00 | 1 |
BX Swiss | 2023/02/02 | 18:00 | 289.858 CHF | 0.01 | 1 |
ELI LILLY & CO. |
- - |
Lilly Corporate Center - 46285 Indianapolis |
Telefon: 1-317-276-2000 |
Fax: - |
E-mail: communications_corporate@lilly.com |
Eli Lilly & Co. engages in the discovery, development, manufacture and sale of pharmaceutical products. The firm's products consist of Diabetes, Oncology, Immunology, Neuroscience, and Other therapies. The Diabetes products include Baqsimi, Basaglar, Humalog, Humulin, Jardiance, Lyumjev, Trajenta, and Trulicity. The Oncology products consist of Alimta, Cyramza, Erbitux, Retevmo, Tyvyt, and Verzenio. The Immunology products include Olumiant and Taltz. The Neuroscience products consist of Cymbalta, Emgality, Reyvow, and Zyprexa. The Other therapies include Bamlanivimab, Cialis, and Forteo. The company was founded by Eli Lilly in May 1876 and is headquartered in Indianapolis, IN. |
Katherine Baicker | Member of Board of Directors |
Marschall Runge | Member of Board of Directors |
Mary Lynne Hedley | Member of Board of Directors |
William Kaelin | Member of Board of Directors |
Gabrielle Greene-Sulzberger | Member of Board of Directors |
Jackson Tai | Member of Board of Directors |
Jamere Jackson | Member of Board of Directors |
Jon Fyrwald | Member of Board of Directors |
Juan Luciano | Member of Board of Directors |
Karen Walker | Member of Board of Directors |
Kimberly Johnson | Member of Board of Directors |
Ralph Alvarez | Member of Board of Directors |
David Ricks | Chairman of Managing Board |
Alonzo Weems | Member of Executive Committee |
Daniel Skovronsky | Member of Executive Committee |
Robert Conley | Member of Executive Committee |
Robert Heine | Member of Executive Committee |
Anat Ashkenazi | Member of Executive Committee |
Anat Hakim | Member of Executive Committee |
Andy Vicari | Member of Executive Committee |
Anne White | Member of Executive Committee |
Christian Nguyen | Member of Executive Committee |
Diogo Rau | Member of Executive Committee |
Donald Zakrowski | Member of Executive Committee |
Edgardo Hernandez | Member of Executive Committee |
Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.
By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer